AstroNova Files 8-K on Shareholder Nominations
Ticker: ALOT · Form: 8-K · Filed: Sep 2, 2025 · CIK: 8146
| Field | Detail |
|---|---|
| Company | Astronova, INC. (ALOT) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing
TL;DR
AstroNova filed an 8-K, watch for shareholder nominations.
AI Summary
AstroNova, Inc. filed an 8-K on August 28, 2025, reporting on shareholder nominations and other events. The company, incorporated in Rhode Island with its principal executive offices in West Warwick, RI, previously operated under the names ASTRO MED INC /NEW/ and ATLAN TOL INDUSTRIES INC.
Why It Matters
This filing indicates potential changes or discussions related to the company's board of directors or strategic direction, which could impact shareholders.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate events and does not immediately suggest significant financial or operational risks.
Key Players & Entities
- AstroNova, Inc. (company) — Registrant
- August 28, 2025 (date) — Date of earliest event reported
- Rhode Island (jurisdiction) — State of incorporation
- 600 East Greenwich Avenue West Warwick, RI 02893 (address) — Principal executive offices
- ASTRO MED INC /NEW/ (company) — Former company name
- ATLAN TOL INDUSTRIES INC (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for AstroNova, Inc.?
The primary purpose is to report on shareholder nominations and other events that occurred on or before August 28, 2025.
When was the earliest event reported in this filing?
The earliest event reported was on August 28, 2025.
In which state is AstroNova, Inc. incorporated?
AstroNova, Inc. is incorporated in Rhode Island.
What are AstroNova, Inc.'s principal executive offices?
AstroNova, Inc.'s principal executive offices are located at 600 East Greenwich Avenue, West Warwick, RI 02893.
What were some of AstroNova, Inc.'s former company names?
AstroNova, Inc. was formerly known as ASTRO MED INC /NEW/ and ATLAN TOL INDUSTRIES INC.
Filing Stats: 929 words · 4 min read · ~3 pages · Grade level 12.7 · Accepted 2025-09-02 16:37:46
Key Financial Figures
- $0.05 — ange on which Registered Common Stock, $0.05 Par Value ALOT NASDAQ Global Market
Filing Documents
- d41422d8k.htm (8-K) — 26KB
- 0001193125-25-194065.txt ( ) — 134KB
- alot-20250828.xsd (EX-101.SCH) — 3KB
- alot-20250828_lab.xml (EX-101.LAB) — 17KB
- alot-20250828_pre.xml (EX-101.PRE) — 11KB
- d41422d8k_htm.xml (XML) — 3KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 28, 2025 ASTRONOVA, INC. (Exact name of registrant as specified in its charter) Rhode Island 0-13200 05-0318215 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 600 East Greenwich Avenue West Warwick , RI 02893 (Address of principal executive offices) (Zip Code) (401) 828-4000 Registrant's telephone number, including area code Not applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on which Registered Common Stock, $0.05 Par Value ALOT NASDAQ Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.08 Shareholder Director Nominations. To the extent applicable, the information set forth in Item 8.01 below is incorporated herein by reference. Item8.01 Other Matters. As previously reported, the Board of Directors (the "Board") of AstroNova, Inc. (the "Company") determined to reschedule the Company's 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"), previously scheduled for Wednesday, July 9, 2025. On August 28, 2025, the Board established Tuesday, December 2, 2025 (the "New Meeting Date") as the rescheduled date for the 2025 Annual Meeting. The Board has set October 13, 2025 as the record date relative to the New Meeting Date for the 2025 Annual Meeting. The time, location and means of attending the 2025 Annual Meeting will be specified in the Company's definitive proxy statement on Schedule 14A for the 2025 Annual Meeting. The Company's 2024 Annual Meeting of Shareholders (the "2024 Annual Meeting") was held on June 11, 2024. As the New Meeting Date is more than 30 days after the first anniversary of the 2024 Annual Meeting, the Company is informing shareholders of this change in accordance with Rule 14a-5(f) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is informing shareholders of the new dates described below for submitting shareholder proposals and other matters for consideration at the 2025 Annual Meeting. Pursuant to Rule 14a-8 of the Exchange Act, a shareholder intending to present a proposal to be included in the proxy statement for the 2025 Annual Meeting must deliver the proposal in writing to the Company's Secretary at its corporate office at 600 East Greenwich Avenue, West Warwick, Rhode Island, 02893 no later than a reasonable time before we begin to print and mail the proxy materials for the 2025 Annual Meeting. To be considered for inclusion in this year's proxy materials for the 2025 Annual Meeting, shareholder proposals must be submitted in writing on or before the close of business on October 3, 2025, which the Company believes to be a reasonable deadline under the applicable rules of the Exchange Act. In addition to complying with such deadline, shareholder proposals intended to be considered for inclusion in the Company's proxy materials for the 2025 Annual Meeting must also comply with Rhode Island law as well as all applicable rules and regulations promulgated by the U.S. Securities and Exchange Commission (the "SEC") under the Exchange Act. Any director nominations and shareholder proposals received after such deadline will be considered untimely and will not be considered for inclusion in the proxy materials for the 2025 Annual Meeting nor will it be considered at the 2025 Annual Meeting. Any shareholder who wishes to make a nomination or introduce an item of business at the 2025 Annual Meeting, other than pursuant to Rule 14a-8 under the Exchange Act, must deliver proper notice to the Company in writing